user

Safety and effectiveness of lu-177 dotatate prrt after regional hepatic radio or chemo embolization in patients with somatostatin expressing neuroendocrine tumors

被引：0
|
作者：
Hamiditabar, Mohammadali [1 ]
Vahdati, Gelareh [1 ]
Amerinia, Reza [1 ]
Delpassand, Ebrahim [1 ]
机构：
[1] Excel Diagnost & Nucl Oncol, Houston, TX USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1436
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendocrine Tumors
    Hamiditabar, Mohammadali
    Ali, Muzammil
    Bolek, Luke
    Vahdati, Gelareh
    Tworowska, Izabela
    Delpassand, Ebrahim S.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (11) : 822 - 828
  • [2] 177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Mileva, Magdalena
    Van Bogaert, Camille
    Marin, Gwennaelle
    Danieli, Rachele
    Artigas, Carlos
    Levillain, Hugo
    Ameye, Lieveke
    Taraji-Schiltz, Loubna
    Stathopoulos, Konstantinos
    Wimana, Zena
    Hendlisz, Alain
    Flamen, Patrick
    Karfis, Ioannis
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 847 - 853
  • [3] Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors
    Abou Jokh Casas, E.
    Pombo Pasin, M. D.
    Pubul Nunez, V.
    Garrido Pumar, M.
    Blanco Freire, M. N.
    Cabezas, J.
    Cameselle, J.
    Berrios, M.
    Argibay, S.
    Ruibal Morell, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S597 - S598
  • [4] Renal Clearance in NET-Patients before and after PRRT with Y-90 DOTATATE and Lu-177 DOTATATE
    Helms, F.
    Felsch, P.
    Knapp, W. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S500 - S500
  • [5] Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors
    Satapathy, Swayamjeet
    Bhattacharya, Anish
    Sood, Ashwani
    Kapoor, Rakesh
    Gupta, Rajesh
    Sood, Apurva
    Sharma, Prashant
    Khosla, Divya
    Mittal, Bhagwant Rai
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (01) : 23 - 29
  • [6] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Yeokyeong Shin
    Bo Hyun Moon
    Baek-Yeol Ryoo
    Heung-Moon Chang
    Kyu-pyo Kim
    Yong Sang Hong
    Tae Won Kim
    Jin-Sook Ryu
    Yong-il Kim
    Changhoon Yoo
    Targeted Oncology, 2024, 19 : 41 - 49
  • [7] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Shin, Yeokyeong
    Moon, Bo Hyun
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Kim, Kyu-pyo
    Hong, Yong Sang
    Kim, Tae Won
    Ryu, Jin-Sook
    Kim, Yong-il
    Yoo, Changhoon
    TARGETED ONCOLOGY, 2024, 19 (01) : 41 - 49
  • [8] 177Lu-DOTATATE (PRRT) in the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEPNETs) versus other tumors
    Jimenez-Fonseca, P.
    Pubul, V
    Bello, P.
    Riesco-Martinez, M. D. C.
    Aller, J.
    Alonso, Garcia P.
    Caballero, E.
    Custodio, A.
    Centeno, Garcia R.
    Teule, A.
    Casanovas, Mitjavila M.
    Carmona-Bayonas, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 147 - 147
  • [9] Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors
    Assi, Hussein A.
    Hornbacker, Kathleen
    Shaheen, Shagufta
    Wittenberg, Theresa
    Silberman, Robyn
    Kunz, Pamela L.
    PANCREAS, 2021, 50 (06) : 890 - 894
  • [10] Intra-arterial PRRT with Lu-177 DOTATATE in Liver-dominant Metastatic Neuroendocrine Tumors: Early Assessment of Efficacy and Toxicity
    Puranik, Ameya D.
    Rangarajan, Venkatesh
    Shetty, Nitin Sudhakar
    Gala, Kunal
    Kulkarni, Suyash
    Mohite, Ashish
    Marotkar, Mandar
    Gawale, Yogesh
    Dev, Indraja D.
    Shrikhande, Shailesh, V
    Chaudhari, Vikram
    Bhandare, Manish
    Agrawal, Archi
    Shah, Sneha
    Purandare, Nilendu C.
    Ghosh, Suchismita
    Choudhury, Sayak
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (02): : 71 - 76
12345